bio:cap europe 2026

bio:cap europe 2026

bio:cap europe

bio:cap is Europe’s Life Science & AI Investival with one clear mission:
connecting breakthrough science to the funding that turns ideas into impact.

We unite global investors, founders, and industry leaders to spotlight and back the most promising innovations emerging from European research. bio:cap transforms cutting-edge science into investable ventures and fast-tracks their journey from lab bench to market front.

Our goal?
to benefit patients and society and to help create a resilient and sustainable European bioeconomy.

What is an Investival?

An Investival combines the best of both worlds: investment and festival.

bio:cap blends the depth of a traditional investor conference with the energy, openness, and creativity of a festival. Expect inspiring keynotes, curated matchmaking, and deep-dive sessions by day – followed by relaxed networking and standout social events in the evening. bio:cap is more than just a conference – it’s where deals, ideas, and visions come to life in a whole new atmosphere.

09 – 11 June 2026
CityCube, Messe Berlin


BioRN members receive a 60 % discount for the first 100 Tickets and 10% discount on booth bookings (valid until March 31, 2026)

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
How is TR-FRET Used in Drug Discovery?

How is TR-FRET Used in Drug Discovery?

This post is Part 2 of a two-part blog series. Read part 1: What is a TR‑FRET assay and how is it used in drug discovery? In a previous blog post, we covered the fundamental principles of Time-Resolved Fluorescence (TR) Förster Resonance Energy Transfer (TR-FRET), including how long-lived lanthanide donors like europium enable high-sensitivity, “mix-and-read” assays. Because TR-FRET provides a ratiometric, proximity-based […]

Triple ERC Success at the German Cancer Research Center

Triple ERC Success at the German Cancer Research Center

Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain […]

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM) have identified a previously unknown mechanism that can drive cancer cachexia – a wasting process in the body that primarily affects muscle and fat tissue. A central role is […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp